The time course of the loss in presynaptic dopamine transporters (DAT) and of the increase in postsynaptic dopamine D2 receptors (D2R) was studied in a rat model of Parkinson's disease. For this, in vitro autoradiographic experiments were performed in the striatum using (E)-N-(3-iodoprop-2-enyl)-2be
Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: In vivo imaging with [18F]fallypride
✍ Scribed by Marta G. Vučcković; Quanzheng Li; Beth Fisher; Angelo Nacca; Richard M. Leahy; John P. Walsh; Jogesh Mukherjee; Celia Williams; Michael W. Jakowec; Giselle M. Petzinger
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 291 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The purpose of the current study was to examine changes in dopamine D2 receptor (DA‐D2R) expression within the basal ganglia of MPTP mice subjected to intensive treadmill exercise. Using Western immunoblotting analysis of synaptoneurosomes and in vivo positron emission tomography (PET) imaging employing the DA‐D2R specific ligand [^18^F]fallypride, we found that high intensity treadmill exercise led to an increase in striatal DA‐D2R expression that was most pronounced in MPTP compared to saline treated mice. Exercise‐induced changes in the DA‐D2R in the dopamine‐depleted basal ganglia are consistent with the potential role of this receptor in modulating medium spiny neurons (MSNs) function and behavioral recovery. Importantly, findings from this study support the rationale for using PET imaging with [^18^F]fallypride to examine DA‐D2R changes in individuals with Parkinson's Disease (PD) undergoing high‐intensity treadmill training. © 2010 Movement Disorder Society.
📜 SIMILAR VOLUMES
1-aminomethyl-5,6-dihydroxy-3-phenylisochroman; NMDA antagonist; CPP; 3-((6)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid